Chrysa Nikolopoulou

Statistics

Publications

Citations

361

H-Index

Active since

2004

Affiliations

VA Boston Healthcare System(Current)

Chrysa Nikolopoulou is an author at VA Boston Healthcare System specializing in liver disease, diabetes control, and peroxisome proliferator-activated receptor signaling.

Publications per year

2004–2021

Publications

Empagliflozin Attenuates Non-Alcoholic Fatty Liver Disease (NAFLD) in High Fat Diet Fed ApoE(-/-) Mice by Activating Autophagy and Reducing ER Stress and Apoptosis

Narjes Nasiri‐Ansari, Chrysa Nikolopoulou, Katerina Papoutsi et al. · International Journal of Molecular Sciences · 2021 · 293 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

1–2 of 2